Literature DB >> 19205713

Combined chemotherapy with paclitaxel and carboplatin for mucinous cystadenocarcinoma of the ovary during pregnancy.

Daisuke Doi1, Yumi Boh, Hideki Konishi, Hirobumi Asakura, Toshiyuki Takeshita.   

Abstract

Combined chemotherapy using carboplatin and paclitaxel has been established as a standard regimen for epithelial ovarian carcinoma. We present the case of a 36-year-old woman with ovarian mucinous cystadenocarcinoma who underwent exploratory laparotomy during pregnancy, revealing Stage 1c at gestational week 15. Afterwards, five courses of paclitaxel and carboplatin chemotherapy were administered biweekly from gestational week 24. Cesarean section was performed at gestational week 36. No recurrent or metastatic lesions were found and outcomes for both mother and neonate have been satisfactory for 40 months since diagnosis of ovarian carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205713     DOI: 10.1007/s00404-009-0950-2

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

Review 1.  Treatment of recurrent vulvar Paget disease with imiquimod cream: a case report and review of the literature.

Authors:  Esra Tonguc; Tayfun Güngor; Turgut Var; Mustafa Ozat; Izzet Sahin; Levent Sirvan
Journal:  Arch Gynecol Obstet       Date:  2010-08-29       Impact factor: 2.344

Review 2.  Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature.

Authors:  Krystyna Serkies; Ewa Węgrzynowicz; Jacek Jassem
Journal:  Arch Gynecol Obstet       Date:  2011-03-03       Impact factor: 2.344

Review 3.  Ovarian dysgerminoma in pregnancy: A case report and literature review.

Authors:  Yuanyuan Chen; Ying Luo; Cha Han; Wenyan Tian; Wen Yang; Yingmei Wang; Fengxia Xue
Journal:  Cancer Biol Ther       Date:  2018-04-25       Impact factor: 4.742

Review 4.  Does Chemotherapy for Gynecological Malignancies during Pregnancy Cause Fetal Growth Restriction?

Authors:  Nabil Abdalla; Magdalena Bizoń; Robert Piórkowski; Paweł Stanirowski; Krzysztof Cendrowski; Włodzimierz Sawicki
Journal:  Biomed Res Int       Date:  2017-05-24       Impact factor: 3.411

Review 5.  A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives.

Authors:  Stergios Boussios; Michele Moschetta; Konstantina Tatsi; Alexandros K Tsiouris; Nicholas Pavlidis
Journal:  J Adv Res       Date:  2018-03-06       Impact factor: 10.479

Review 6.  Efficacy and Safety of Platinum-Based Chemotherapy for Ovarian Cancer During Pregnancy: A Systematic Review and Meta-Analysis.

Authors:  Yaping Pei; Yuanfeng Gou; Na Li; Xiaojuan Yang; Xue Han; Liu Huiling
Journal:  Oncol Ther       Date:  2021-12-04

7.  Long-term multidisciplinary integrative therapy management resulted in favorable outcomes for ovarian cancer during pregnancy: a case report and literature review.

Authors:  Tianmin Xu; Liang Wang; Yan Jia; Zanhui Jia; Zhuo Li; Shaohai Cui; Manhua Cui
Journal:  J Ovarian Res       Date:  2019-11-11       Impact factor: 4.234

Review 8.  Pregnancy with giant ovarian dysgerminoma: A case report and literature review.

Authors:  Xi-Wen Zhang; Li-Rong Zhai; Dong-Wei Huang; Zhen-De Jiang; Tong Yu; Shu-Yan Liu; Man-Hua Cui
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.